Vascular Immunometabolism in Atherosclerosis: Emerging Roles of Glycometabolic Reprogramming in Immune and Vascular Cells.

Li H, Song A, Zhang J, Dong H, Li X, Zhao Y

Open source

DOI
10.1007/s10557-026-07956-6
Published
2026 Sep 10
Container
Cardiovascular drugs and therapy
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s10557-026-07956-6,
  title = {Vascular Immunometabolism in Atherosclerosis: Emerging Roles of Glycometabolic Reprogramming in Immune and Vascular Cells.},
  author = {Li H and Song A and Zhang J and Dong H and Li X and Zhao Y},
  year = {2026},
  journal = {Cardiovascular drugs and therapy},
  doi = {10.1007/s10557-026-07956-6},
  url = {https://doi.org/10.1007/s10557-026-07956-6}
}

RIS

TY  - JOUR
TI  - Vascular Immunometabolism in Atherosclerosis: Emerging Roles of Glycometabolic Reprogramming in Immune and Vascular Cells.
AU  - Li H
AU  - Song A
AU  - Zhang J
AU  - Dong H
AU  - Li X
AU  - Zhao Y
PY  - 2026
JO  - Cardiovascular drugs and therapy
DO  - 10.1007/s10557-026-07956-6
UR  - https://doi.org/10.1007/s10557-026-07956-6
ER  - 

APA

H, L., A, S., J, Z., H, D., X, L., & Y, Z. (2026). Vascular Immunometabolism in Atherosclerosis: Emerging Roles of Glycometabolic Reprogramming in Immune and Vascular Cells.. Cardiovascular drugs and therapy. https://doi.org/10.1007/s10557-026-07956-6

Source records